Input the clinical health metrics and aneurysm morphology to establish the international consensus treatment recommendation.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Guiding the management of patients with asymptomatic, unruptured intracranial aneurysms.
Standardizing treatment algorithms among neurosurgeons, neurologists, and neuroradiologists.
Balancing clinical data (age, comorbidities) with radiographic data (size, location, morphology).
Section 2
Literature
Development
The UIATS was created by a panel of 39 world-renowned neurovascular experts using a Delphi-consensus method. It was designed to bridge the gap in level 1 evidence for unruptured aneurysms by quantifying expert clinical intuition into a weighted decision model.
Section 3
Pearls/Pitfalls
Beyond Rupture Risk
Unlike the PHASES score which only predicts natural history, the UIATS specifically includes a "Pro-Treatment" vs. "Pro-Observation" scoring system. It considers psychological factors (patient anxiety), technical factors (intervention difficulty), and morphological stability, making it more applicable to real-world surgical clinic scenarios.
Section 4
Evidence Appraisal
Primary Reference
The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus
